According to the latest report by IMARC Group, titled “Blood Culture Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” the global blood culture test market size reached US$ 4.3 Billion in 2021. A blood culture test is used to check foreign invaders like yeast, bacteria, and other microorganisms in the blood. It relies on the blood sample of an individual obtained via sterile technique, which is kept in culture media and incubated in a controlled environment for a few days. the results help in determining the pathogens causing the infection and possible methods for combating the disease.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Blood Culture Test Market Trends:
The global market is primarily driven by the rising incidences of bloodstream infections (BSI), sepsis and environment-borne diseases. Besides this, the increasing prevalence of chronic diseases, especially among the geriatric population, which is relatively more prone to medical ailments, is also contributing to the market growth. Furthermore, leading players are focusing on launching novel diagnostic techniques to reduce diagnosis time, eliminate manual errors and offer early prevention of infections. This, along with the increased cases of coronavirus disease (COVID-19) during the year 2020 and 2021, has escalated the demand for blood culture tests. Looking forward, the market value is projected to reach US$ 7.1 Billion by 2027, expanding at a CAGR of 8.77% during the forecast period (2022-2027).
- Based on the testing method, the market has been bifurcated into conventional and automated segments.
- On the basis of the product, the market has been divided into consumables, instruments, and software and services. The consumables segment is further categorized into blood culture media (aerobic, anerobic, fungi/yeast, mycobacterial blood culture media), assay kits and reagents, and blood culture accessories. On the other hand, the instruments segment includes automated blood culture systems and supporting laboratory equipment (incubators, colony counters, microscopes and gram stainers).
- Based on the technology, the market has been classified into culture-based, molecular (microarray, PCR and PNA-FISH), proteomic and other technologies.
- On the basis of the application, the market has been segregated into bacterial, fungal and mycobacterial infections.
- Based on the end user, the market has been divided into hospitals, references, research and other laboratories.
- Region-wise, the market has been categorized into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Europe (the United Kingdom, Germany, France, Italy, Spain, Russia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
- The competitive landscape of the market has been examined, with some of the key players being Abbott Laboratories, Danaher Corporation, Becton, Dickinson and Company, bioMeriux SA, Bruker Corporation, Luminex Corporation, Merck KGaA, Siemens Healthcare GmbH, F.Hoffmann-La Roche Ltd., T2 Biosystems Inc. and Thermo Fisher Scientific Company.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Follow us on twitter : @imarcglobal